Paclitaxel is a potent cytotoxic medication derived from the needles of the Pacific Yew tree (Taxus brevifolia). It belongs to the "Taxane" class of antineoplastics. It works by binding to the "microtubules" within cancer cells—the structural "scaffolding" cells need to divide. Unlike other drugs that prevent microtubule formation, Paclitaxel stabilizes them, making them too rigid to function. This prevents the cancer cells from completing "mitosis" (cell division), eventually triggering programmed cell death (apoptosis).
In Nigeria, Paclitaxel Injection (available in brands like Taxol, Anzatax, or quality oncology generics) is a foundational treatment for several major malignancies. It is available through specialized oncology pharmacies like Sanlive Pharmacy to ensure hospitals receive authentic, high-stability vials manufactured under strict global standards. The "Specialized Storage" Rule: Vials should be stored at room temperature (below 25°C) and protected from strong light until they are ready for professional reconstitution.
Important: This is a high-alert chemotherapy agent. The "Pre-medication" Rule: To prevent severe allergic reactions (hypersensitivity), patients must receive pre-treatment with a steroid (Dexamethasone), an antihistamine (Diphenhydramine), and an H2 blocker (Ranitidine) several hours before the infusion. The "Non-PVC" Rule: Paclitaxel reacts with standard plastic (PVC) IV bags and tubing. It must be prepared and administered using "Non-PVC" or "Glass" containers and specialized 0.22-micron filters.
Paclitaxel Injection is primarily used to:
Treat Metastatic Ovarian Cancer, often as first-line therapy with Carboplatin
Manage Advanced Breast Cancer after failure of standard combination therapy
Treat Non-Small Cell Lung Cancer (NSCLC) in patients not candidates for surgery
Manage AIDS-related Kaposi's Sarcoma that has not responded to other treatments
Act as an "Adjuvant" therapy after surgery to reduce the risk of cancer recurrence
Provide rapid "Tumor Shrinkage" in aggressive, rapidly dividing solid tumors
Stabilize advanced-stage disease and improve the quality of life for oncology patients
This product is suitable for:
Adults with confirmed diagnoses of ovarian, breast, lung, or Kaposi's sarcoma
Patients whose cancers have shown resistance to "anthracycline" (Adriamycin) therapy
Individuals undergoing intensive multi-drug oncology regimens in a clinical setting
Not recommended for: Patients with a baseline neutrophil count below $1,500\text{ cells/mm}^3$. It is strictly contraindicated for individuals with a severe allergy to "Cremophor EL" (polyoxyethylated castor oil), which is the vehicle used to dissolve the drug. Use with extreme caution in patients with pre-existing "Peripheral Neuropathy" (numbness/tingling in hands/feet), as Paclitaxel can worsen this condition. Consult our pharmacist if the patient has severe liver impairment, as the dose must be reduced to avoid dangerous toxicity.
Administered strictly via Intravenous (IV) Infusion; it must never be given by any other route
The "Slow Infusion" Rule: It is typically infused over 3 hours or 24 hours, depending on the specific protocol and the type of cancer being treated
The "Filter" Tip: A 0.22-micron "in-line" filter must be used during administration to catch any microscopic particles or precipitates
Dosing: Dosage is strictly calculated based on Body Surface Area ($mg/m^2$) and is usually repeated every 3 weeks
The "Extravasation" Warning: This drug is an "irritant." If the IV site leaks, it can cause pain and inflammation; notify the nurse immediately if you feel burning
Regular blood counts (CBC) and liver function tests are mandatory before every single treatment cycle
Paclitaxel is highly effective, but most patients will experience:
Bone Marrow Suppression: Low white blood cells (increasing infection risk) and low platelets
Peripheral Neuropathy: Numbness, tingling, or "pins and needles" in the fingers and toes
Total Alopecia: Complete hair loss (usually including eyebrows and eyelashes)
Arthralgia/Myalgia: Joint and muscle pain, often occurring 2–3 days after the infusion
Nausea, vomiting, and mouth sores (mucositis)
Rare but serious: Severe Hypersensitivity (shortness of breath, drop in blood pressure, or hives)
Rare: Abnormal heart rhythm (bradycardia) during the infusion
Rare: Nail changes (brittleness or discoloration)
Seek immediate medical attention if the patient develops a fever over 38°C, sudden difficulty breathing, swelling of the face, or intense pain/numbness that prevents walking.
Reputable global oncology firms (such as Bristol-Myers Squibb, Hospira, or quality generic manufacturers) – These firms ensure the high-purity extraction and stabilization of the drug in the required non-aqueous solvent.
100% authentic oncology medication—guaranteed original and high-potency stock
Guaranteed high-quality vials stored in optimal, climate-controlled, and light-protected conditions
Professional guidance from licensed pharmacists specialized in hazardous drug handling and Non-PVC supplies
Secure and rapid delivery to oncology centers and private hospitals across Nigeria
Will my hair grow back?
Yes. Hair loss with Paclitaxel is almost always temporary. Hair typically begins to grow back 3 to 6 months after the final treatment, though it may initially have a different texture or color.
Can I drive home after the infusion?
Usually, no. Because the pre-medications often include an antihistamine (like Diphenhydramine) that causes heavy drowsiness, you should have someone drive you home after your appointment.
Why do I need to take so many pills before the injection?
The pre-medication "cocktail" is vital to prevent a severe allergic reaction to the oil-based liquid used to dissolve Paclitaxel. Skipping these pills can make the infusion very dangerous.
Where can I purchase Paclitaxel Injection in Nigeria?
Hospitals and oncology clinics can source verified Paclitaxel through Sanlive Pharmacy & Stores for guaranteed product integrity and professional oncology support.
No reviews yet.
Login to write a review.
Related Products
.jpg)
